mediaire transforms radiology with AI, securing a European €12 million investment to fuel global growth

News Article

Berlin, Paris, 13 November 2024 – While Generative AI is creating a buzz across industries and remains in the early stages of the hype cycle, AI in radiology is no longer just a vision for the future. mediaire’s proven AI value is already happening in over 350 hospitals and clinics across Europe, where the German radiology innovator’s AI portfolio is transforming how radiologists work. With this success, mediaire has secured a €12 million European-led financing round, headed by lead investor LBO France with participation from IBB Ventures and the Swiss family office Wille Finance. It highlights the importance of demonstrating that AI technology truly works in clinical practice. The oversubscribed financing round included continued support from existing investors HTGF, LIFTT, and Gateway Ventures.

By seamlessly integrating AI into daily diagnostics, mediaire is lifting the burden of routine analysis off the shoulders of radiologists, reducing medical workload, and improving patient outcomes. Thanks to the recent investment mediaire is set to expand its AI portfolio beyond brain, prostate, and knee diagnostics in magnetic resonance imaging (MRI). This next wave of innovation will tackle even more AI solutions, bringing AI-driven accuracy and efficiency to doctors globally. The funding marks a new phase in the company’s growth.

“Our AI solutions are not a futuristic dream. We have already created a reality that is helping doctors make better decisions and giving patients faster answers,” says Dr. Andreas Lemke, CEO, and co-founder of mediaire. “We are seeing the impact on thousands of radiologists every day in hundreds of hospitals and radiology practices across Europe that are utilizing our AI solutions. With this investment, we will be able to scale these benefits to even more healthcare providers.”

“We believe in the power of technology to improve lives,” said Matthes Seeling, LBO France’s Investment Director. “mediaire’s focus aligns perfectly with our firm belief in the transformative power of healthcare technology to the benefit of all professionals and patients. The dedicated team meets a crucial need in the healthcare sector considering the increasing global demand for fast, accurate and affordable diagnostics. With this investment, we will actively sustain mediaire’s growth to achieve its ambitious objectives and consolidate its position as a leader in radiology AI in Europe.”

Integral to mediaire’s success story are partnerships with renowned university hospitals and industry leaders such as Bayer/Calantic, Sectra, deepc, as well as radiology chains like Med360, Evidia, Starvision, and RIMED/UNILABS.

Dr. Angelika Vlachou, Partner at HTGF, said: “We at HTGF have been very pleased with mediaire’s development over the past years, and believe the team has demonstrated the value it can add to its customers, the radiologists. The field of AI-based tools is advancing rapidly, and to be successful, companies need to demonstrate true product innovation that is precisely tailored to customer needs. We are excited to continue to support mediaire’s development.”

From left to right: Barbara von Horstig (Hemmelrath Law), Christian Seegers (IBB Ventures), Matthes Seeling (LBO France), Matthias Hofreiter (Gateway Ventures), Dr. Andreas Lemke (mediaire), Dr. Jörg Döpfert (mediaire), Franck Noiret (LBO France), Max Rüther (RSR Rüping Schroeder Rechtsanwälte for Wille Finance), Sebastian Burian (Representative of a private investor consortium), Teresa De Nadai (LIFTT) – Image rights: mediaire, Leander von Thien

About mediaire
mediaire develops AI-powered diagnostic solutions for MRI imaging, focusing on the seamless integration of AI into clinical workflows to enhance radiologists’ efficiency and diagnostic accuracy. The company’s AI solutions, including mdbrain, mdprostate, and mdknee, provide automated decision support that improves the quality of diagnostics while optimizing workflow efficiency. With a strong international presence and new products in development, mediaire is positioned to lead the future of MRI AI in radiology. For more information: https://mediaire.ai/en/

Media contact
Natalie Erdmann
press@mediaire.de

About HTGF – High-Tech Gründerfonds 
HTGF is one of the leading and most active early-stage investors in Germany and Europe, financing start-ups in the fields of Deep Tech, Industrial Tech, Climate Tech, Digital Tech, Life Sciences and Chemistry. With its experienced investment team, HTGF supports start-ups in all phases of their development into international market leaders. HTGF invests in pre-seed and seed phases and can participate significantly in later-stage financing rounds. Across its funds, HTGF has over 2 billion euros under management. Since its inception in 2005, HTGF has financed more than 770 start-ups and achieved over 180 successful exits.  
Fund investors in the public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital as well as 45 companies and family offices.  
For more information, please visit HTGF.de or follow us on LinkedIn.   

Media contact 
High-Tech Gründerfonds Management GmbH 
Tobias Jacob, Senior Marketing & Communications Manager  
T.: +49 228 – 82300 – 121 
t.jacob@htgf.de   

Do you want to

mehr erfahren?

Zum Artikel

Dr. Angelika Vlachou Partner

Dr. Angelika VlachouPartner

I am your contact

for all press inquiries:
Tobias Jacob

More News

Last update 1 days ago
Zum Artikel

News

29. April 2025

eeden Closes €18M Series A Financing to Scale its Breakthrough Textile Recycling Technology

Zum Artikel

News

28. April 2025

DXI takes customer interaction to a new level: Pre-seed financing secures AI leadership in the field of “digital customer twins” 

Zum Artikel

News

24. April 2025

ATMOS Space Cargo Conducts First Re-Entry Mission from Space early on its way to building a leading return logistics platform with its Innovative Return Capsule

Zum Artikel

News

23. April 2025

node.energy raises €15 million in Series B financing

Zum Artikel

News

15. April 2025

HepaRegeniX completes €21.5 million financing to support clinical advancement of HRX-215 for liver regeneration

Zum Artikel

News

7. April 2025

Successful exit for HTGF: German Medical Engineering joins the Thomas Group